Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00896272 · ClinicalTrials.gov registry record

Adaptation Among Adolescents and Adults With Klinefelter Syndrome

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
302
Enrollment target

NCT00896272: Completed study, sponsored by National Human Genome Research Institute (NHGRI).

NCT00896272 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 302 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00896272 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
302 participants
Enrollment target

Study Summary

This study aims to understand the impact of living with Klinefelter syndrome (KS) and the factors that contribute to adaptation in adolescents and adults. Individuals with KS may have variable symptoms, including hypogonadism, gynecomastia, learning disabilities, and delay and underdevelopment of secondary sexual characteristics. Perhaps the most challenging symptom of KS is infertility, which seems to be a universal symptom. It is not fully understood how males with KS conceptualize their condition, cope with their diagnosis, and adapt to living with this condition. In this study, Lazarus and Folkman s Transactional Model of Stress and Coping provides a framework for examining coping and adaptation in males with KS. A cross-sectional research design using a quantitative survey will be utilized to examine the relationships among appraisals (illness perceptions and perceived stigma), time elapsed since learning of diagnosis, coping, and adaptation. Adolescents and adults with KS will be recruited from national KS support networks via website postings, email listservs, and printed newsletter postings. Adolescents will also be recruited from a private practice. Participants will have the option to complete an online or paper version of the survey. The main outcome variable is adaptation to living with a KS diagnosis.

Trial Details

FieldValue
Enrollment Target 302 participants
Start Date 2009-05-05
Est. Completion 2015-01-13

What the finished NCT00896272 record still lists

NCT00896272 is an observational study that tracks outcomes without assigning an intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00896272 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00896272 about?

NCT00896272 is a clinical study titled "Adaptation Among Adolescents and Adults With Klinefelter Syndrome". This study aims to understand the impact of living with Klinefelter syndrome (KS) and the factors that contribute to adaptation in adolescents and adults. Individuals with KS may have variable symptoms, including hypogonadism, gynecomastia, learning disabilities, and delay and underdevelopment of se...

What is the current status of trial NCT00896272?

This trial is currently completed. The enrollment target is 302 participants. The study started on 2009-05-05. Estimated completion is 2015-01-13.

Who is sponsoring clinical trial NCT00896272?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05722561 · 302 participants · Phase 2

    E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

  • NCT06015737 · 302 participants · Phase 3

    A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

  • NCT07176273 · 302 participants · NA

    Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)

  • NCT05508971 · 303 participants · NA

    Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00896272, the US trial registry maintained by the National Library of Medicine. NCT00896272 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.